NCXX Group
6634
Leoclan
7681
Timee
215A
Mirairo Inc.
335A
Marusho Hotta
8105
JP Stock MarketDetailed Quotes
4506 Sumitomo Pharma
- 727
- +1+0.14%
20min DelayTrading Mar 25 11:30 JST
289.27BMarket Cap-0.92P/E (Static)
727High713Low570.50KVolume726Open726Pre Close410.40MTurnover83852wk High0.33%Turnover Ratio397.90MShares27952wk Low-443.1EPS TTM124.02BFloat Cap4135Historical HighLossP/E (Static)170.59MShs Float279Historical Low-792.79EPS LYR1.93%Amplitude--Dividend TTM1.74P/B100Lot Size--Div YieldTTM
Sumitomo Pharma Key Stats
EPS
According to the latest financial report of Sumitomo Pharma, the latest earnings per share (TTM) for the company is 134.53. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Sumitomo Pharma's free cash flow? The latest report shows it as 931.00M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Sumitomo Pharma shows that the company's current ratio is 0.67, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Sumitomo Pharma, the quick ratio is 0.39, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Sumitomo Pharma? The latest ROE figure is 38.14%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Sumitomo Pharma, the total asset return on investment (ROA) is 6.47%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Sumitomo Pharma's latest financial report to see how their gross margin is doing - currently at 63.14%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Sumitomo Pharma, the net profit margin is 47.54%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...